Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

"Making weight" during military service is related to binge eating and eating pathology for veterans later in life.

Masheb RM, Kutz AM, Marsh AG, Min KM, Ruser CB, Dorflinger LM.

Eat Weight Disord. 2019 Dec;24(6):1063-1070. doi: 10.1007/s40519-019-00766-w. Epub 2019 Aug 30.

PMID:
31471885
2.

Corrigendum to "Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women" [Contraception 99 (2019) 199-204].

Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.

Contraception. 2019 Jul;100(1):88. doi: 10.1016/j.contraception.2019.05.014. No abstract available.

PMID:
31229224
3.

Planning for Outcomes (P4O) Modeling Tool: Estimating the Impact of Changing the Proportion of Injectable Progestins in the Contraceptive Method Mix.

Lebetkin E, Gao X, Taylor D, Maldonado LY, Saad A, Steiner MJ, Dorflinger LJ, Nanda K, Mastro TD.

Glob Health Sci Pract. 2019 Jun 27;7(2):317-328. doi: 10.9745/GHSP-D-19-00062. Print 2019 Jun.

4.

Self-report versus objective measurement of weight history: implications for pre-treatment weight gain.

Phimphasone-Brady P, Dorflinger LM, Ruser C, Bullock A, Godfrey KM, Hernandez D, Min KM, Masheb RM.

J Behav Med. 2019 Dec;42(6):1142-1147. doi: 10.1007/s10865-019-00045-0. Epub 2019 Apr 23.

PMID:
31016640
5.

Patient-reported outcomes (PROs) in lung cancer: Experiences from a nationwide feasibility study.

Brønserud MM, Iachina M, Green A, Groenvold M, Dørflinger L, Jakobsen E.

Lung Cancer. 2019 Feb;128:67-73. doi: 10.1016/j.lungcan.2018.12.014. Epub 2018 Dec 17.

PMID:
30642456
6.

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.

Heffron R, Achilles SL, Dorflinger LJ, Hapgood JP, Kiarie J, Polis CB, Steyn PS.

Contraception. 2019 Apr;99(4):199-204. doi: 10.1016/j.contraception.2018.12.001. Epub 2018 Dec 18. Erratum in: Contraception. 2019 Jul;100(1):88.

7.

Project STEP: Implementing the Veterans Health Administration's Stepped Care Model of Pain Management.

Edmond SN, Moore BA, Dorflinger LM, Goulet JL, Becker WC, Heapy AA, Sellinger JJ, Lee AW, Levin FL, Ruser CB, Kerns RD.

Pain Med. 2018 Sep 1;19(suppl_1):S30-S37. doi: 10.1093/pm/pny094.

PMID:
30203015
8.

PTSD is associated with emotional eating among veterans seeking treatment for overweight/obesity.

Dorflinger LM, Masheb RM.

Eat Behav. 2018 Dec;31:8-11. doi: 10.1016/j.eatbeh.2018.07.005. Epub 2018 Jul 18.

PMID:
30048898
9.

Pain and modifiable risk factors among weight loss seeking Veterans with overweight.

Godfrey KM, Bullock AJ, Dorflinger LM, Min KM, Ruser CB, Masheb RM.

Appetite. 2018 Sep 1;128:100-105. doi: 10.1016/j.appet.2018.06.010. Epub 2018 Jun 6.

PMID:
29885382
10.

Does food addiction contribute to excess weight among clinic patients seeking weight reduction? Examination of the Modified Yale Food Addiction Survey.

Masheb RM, Ruser CB, Min KM, Bullock AJ, Dorflinger LM.

Compr Psychiatry. 2018 Jul;84:1-6. doi: 10.1016/j.comppsych.2018.03.006. Epub 2018 Apr 4.

PMID:
29654930
11.

Assessing Living Donor Priorities Through Nominal Group Technique.

Dorflinger LM, Kulkarni S, Thiessen C, Klarman S, Fraenkel L.

Prog Transplant. 2018 Mar;28(1):29-35. doi: 10.1177/1526924817746682. Epub 2017 Dec 15.

12.

Night eating among veterans with obesity.

Dorflinger LM, Ruser CB, Masheb RM.

Appetite. 2017 Oct 1;117:330-334. doi: 10.1016/j.appet.2017.07.011. Epub 2017 Jul 12.

PMID:
28711610
13.

A brief screening measure for binge eating in primary care.

Dorflinger LM, Ruser CB, Masheb RM.

Eat Behav. 2017 Aug;26:163-166. doi: 10.1016/j.eatbeh.2017.03.009. Epub 2017 Mar 30.

PMID:
28402901
14.

Barriers and facilitators to use of non-pharmacological treatments in chronic pain.

Becker WC, Dorflinger L, Edmond SN, Islam L, Heapy AA, Fraenkel L.

BMC Fam Pract. 2017 Mar 20;18(1):41. doi: 10.1186/s12875-017-0608-2.

15.

Injectable contraception: updates and innovation.

Schivone G, Dorflinger L, Halpern V.

Curr Opin Obstet Gynecol. 2016 Dec;28(6):504-509. Review.

PMID:
27787287
16.

Binge abstinence is associated with reduced energy intake after treatment in patients with binge eating disorder and obesity.

Masheb RM, Dorflinger LM, Rolls BJ, Mitchell DC, Grilo CM.

Obesity (Silver Spring). 2016 Dec;24(12):2491-2496. doi: 10.1002/oby.21664. Epub 2016 Oct 31.

17.

Stepped care model of pain management and quality of pain care in long-term opioid therapy.

Moore BA, Anderson D, Dorflinger L, Zlateva I, Lee A, Gilliam W, Tian T, Khatri K, Ruser CB, Kerns RD.

J Rehabil Res Dev. 2016;53(1):137-46. doi: 10.1682/JRRD.2014.10.0254.

18.

The elusive minimum threshold concentration of levonorgestrel for contraceptive efficacy.

Cherala G, Edelman A, Dorflinger L, Stanczyk FZ.

Contraception. 2016 Aug;94(2):104-8. doi: 10.1016/j.contraception.2016.03.010. Epub 2016 Mar 18. No abstract available.

PMID:
27000997
19.

Training primary care physicians in cognitive behavioral therapy: A review of the literature.

Dorflinger LM, Fortin AH 6th, Foran-Tuller KA.

Patient Educ Couns. 2016 Aug;99(8):1285-92. doi: 10.1016/j.pec.2016.02.014. Epub 2016 Mar 2. Review.

PMID:
26979474
20.

Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial.

Nanda K, Callahan R, Taylor D, Wang M, Agot K, Jenkins D, Van Damme L, Dorflinger L; FEM-PrEP Study Group.

Contraception. 2016 Jul;94(1):40-7. doi: 10.1016/j.contraception.2016.03.003. Epub 2016 Mar 10.

21.

Prevalence and correlates of painful conditions and multimorbidity in national sample of overweight/obese Veterans.

Higgins DM, Buta E, Dorflinger L, Masheb RM, Ruser CB, Goulet JL, Heapy AA.

J Rehabil Res Dev. 2016;53(1):71-82. doi: 10.1682/JRRD.2014.10.0251.

22.

AmbuFlex: tele-patient-reported outcomes (telePRO) as the basis for follow-up in chronic and malignant diseases.

Schougaard LM, Larsen LP, Jessen A, Sidenius P, Dorflinger L, de Thurah A, Hjollund NH.

Qual Life Res. 2016 Mar;25(3):525-34. doi: 10.1007/s11136-015-1207-0. Epub 2016 Jan 20.

23.

Addressing gaps in the contraceptive method mix: methods in development.

Nanda K, Callahan R, Dorflinger L.

Womens Health (Lond). 2015 Nov;11(6):729-35. doi: 10.2217/whe.15.84. Epub 2015 Dec 17.

PMID:
26674125
24.

WHO Tiered-Effectiveness Counseling Is Rights-Based Family Planning.

Stanback J, Steiner M, Dorflinger L, Solo J, Cates W Jr.

Glob Health Sci Pract. 2015 Aug 12;3(3):352-7. doi: 10.9745/GHSP-D-15-00096. Review. No abstract available.

25.

In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant data.

Callahan RL, Taylor D, Jenkins DW, Owen DH, Cheng L, Cancel AM, Dorflinger LJ, Steiner MJ.

Contraception. 2015 Oct;92(4):350-5. doi: 10.1016/j.contraception.2015.06.028. Epub 2015 Jul 2.

26.

[An introduction to patient reported outcome measures in quality assessment].

Dørflinger LH, Knudsen JL.

Ugeskr Laeger. 2015 May 4;177(19). pii: V07140381. Review. Danish.

PMID:
25967089
27.

Towards the development of a longer-acting injectable contraceptive: past research and current trends.

Halpern V, Stalter RM, Owen DH, Dorflinger LJ, Lendvay A, Rademacher KH.

Contraception. 2015 Jul;92(1):3-9. doi: 10.1016/j.contraception.2015.02.014. Epub 2015 Mar 4. Review.

28.

A partnered approach to opioid management, guideline concordant care and the stepped care model of pain management.

Dorflinger L, Moore B, Goulet J, Becker W, Heapy AA, Sellinger JJ, Kerns RD.

J Gen Intern Med. 2014 Dec;29 Suppl 4:870-6. doi: 10.1007/s11606-014-3019-2.

29.

Psychometric properties of a MOVE!23 subscale: Perceived Contributors to Weight Change in a national sample of veterans.

Higgins DM, Buta E, Dorflinger L, Heapy AA, Ruser CB, Goulet JL, Masheb RM.

J Health Psychol. 2016 Jul;21(7):1394-403. doi: 10.1177/1359105314554530. Epub 2014 Oct 7.

PMID:
25293969
30.

Integrating interdisciplinary pain management into primary care: development and implementation of a novel clinical program.

Dorflinger LM, Ruser C, Sellinger J, Edens EL, Kerns RD, Becker WC.

Pain Med. 2014 Dec;15(12):2046-54. doi: 10.1111/pme.12554. Epub 2014 Sep 19.

PMID:
25234837
31.

Development and application of an electronic health record information extraction tool to assess quality of pain management in primary care.

Dorflinger LM, Gilliam WP, Lee AW, Kerns RD.

Transl Behav Med. 2014 Jun;4(2):184-9. doi: 10.1007/s13142-014-0260-5.

32.

Providers' roles in enhancing patients' adherence to pain self management.

Dorflinger L, Kerns RD, Auerbach SM.

Transl Behav Med. 2013 Mar;3(1):39-46. doi: 10.1007/s13142-012-0158-z.

33.

Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm.

Halpern V, Combes SL, Dorflinger LJ, Weiner DH, Archer DF.

Contraception. 2014 Jan;89(1):31-5. doi: 10.1016/j.contraception.2013.07.002. Epub 2013 Jul 12.

PMID:
23993431
34.

Psychosocial factors associated with binge eating among overweight and obese male veterans.

Rosenberger PH, Dorflinger L.

Eat Behav. 2013 Aug;14(3):401-4. doi: 10.1016/j.eatbeh.2013.06.006. Epub 2013 Jun 15.

PMID:
23910790
35.

Binge eating behavior among a national sample of overweight and obese veterans.

Higgins DM, Dorflinger L, MacGregor KL, Heapy AA, Goulet JL, Ruser C.

Obesity (Silver Spring). 2013 May;21(5):900-3. doi: 10.1002/oby.20160. Erratum in: Obesity (Silver Spring). 2014 Aug;22(8):1935-6.

36.

New developments in contraception for US women.

Dorflinger LJ.

Contraception. 2013 Mar;87(3):343-6. doi: 10.1016/j.contraception.2012.12.013. Epub 2013 Jan 10. No abstract available.

PMID:
23380049
37.

Predictors of consent in tissue donation: interpersonal aspects and information provision during requests by phone.

Dorflinger L, Auerbach SM, Siminoff LA.

Patient Educ Couns. 2013 May;91(2):161-6. doi: 10.1016/j.pec.2012.12.003. Epub 2012 Dec 28.

PMID:
23276387
38.

The interpersonal process in tissue donation requests with "undecided" next of kin.

Dorflinger L, Auerbach SM, Siminoff LA.

Prog Transplant. 2012 Dec;22(4):427-34; quiz 435.

39.

Development and implementation of a quality assurance program for a hormonal contraceptive implant.

Owen DH, Jenkins D, Cancel A, Carter E, Dorflinger L, Spieler J, Steiner MJ.

Contraception. 2013 Apr;87(4):473-9. doi: 10.1016/j.contraception.2012.07.010. Epub 2012 Aug 24.

PMID:
22921687
40.

Oncologists' assessments of lung cancer patient and family disagreements regarding treatment decision making.

Siminoff LA, Dorflinger L, Agyemang A, Baker S, Wilson-Genderson M.

Lung Cancer. 2012 Jul;77(1):212-6. doi: 10.1016/j.lungcan.2012.02.008. Epub 2012 Mar 8.

41.

Avoiding controversy in international provision of subdermal contraceptive implants.

Hubacher D, Dorflinger L.

Contraception. 2012 May;85(5):432-3. doi: 10.1016/j.contraception.2011.11.018. Epub 2012 Jan 20. No abstract available.

PMID:
22264665
42.

Sino-implant (II)--a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials.

Steiner MJ, Lopez LM, Grimes DA, Cheng L, Shelton J, Trussell J, Farley TM, Dorflinger L.

Contraception. 2010 Mar;81(3):197-201. doi: 10.1016/j.contraception.2009.10.013. Epub 2009 Dec 5. Review.

43.

Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.

Hubacher D, Lopez L, Steiner MJ, Dorflinger L.

Contraception. 2009 Aug;80(2):113-8. doi: 10.1016/j.contraception.2009.02.008. Epub 2009 Apr 23. Review.

PMID:
19631785
44.

Fear reactivity to bodily sensations among heavy smokers and nonsmokers.

Abrams K, Zvolensky MJ, Dorflinger L, Galatis A, Blank M, Eissenberg T.

Exp Clin Psychopharmacol. 2008 Jun;16(3):230-9. doi: 10.1037/1064-1297.16.3.230.

PMID:
18540783
45.

SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

Peterson L, Nanda K, Opoku BK, Ampofo WK, Owusu-Amoako M, Boakye AY, Rountree W, Troxler A, Dominik R, Roddy R, Dorflinger L.

PLoS One. 2007 Dec 19;2(12):e1312.

46.

Delivery of a healthy baby after first-trimester maternal exposure to lapatinib.

Kelly H, Graham M, Humes E, Dorflinger LJ, Boggess KA, O'Neil BH, Harris J, Spector NL, Dees EC.

Clin Breast Cancer. 2006 Oct;7(4):339-41.

PMID:
17092403
47.

Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial.

Steiner MJ, Dominik R, Rountree RW, Nanda K, Dorflinger LJ.

Obstet Gynecol. 2003 Mar;101(3):539-47. Erratum in: Obstet Gynecol. 2003 May;101(5 Pt 1):1026.

PMID:
12636960
48.
49.

Metabolic effects of implantable steroid contraceptives for women.

Dorflinger LJ.

Contraception. 2002 Jan;65(1):47-62. Review.

PMID:
11861055
50.

Supplemental Content

Loading ...
Support Center